Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Tirzepatide - SURMOUNT-2, SURMOUNT-3 and SURMOUNT-4 On July 27, 2023, Eli Lilly and Company announced results of SURMOUNT-3 and SURMOUNT-4 in adults with obesity or overweight with weight-related comorbidities, excluding type 2 diabetes
Higher concentrations reduce injection volume but require more precise measurement
Everything else is the same across the protocols
We titrate slowly to find the dose your body accepts
The FormBlends Perspective At FormBlends, we follow the clinical trial space closely because it directly informs how we serve our patients
US$ 21.24
US$ 21.15
US$ 27.59
